UK markets close in 15 minutes

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
28.05-1.58 (-5.32%)
As of 11:14AM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Assets
Current assets
Cash
Cash and cash equivalents
39,143
43,836
11,232
24,310
Other short-term investments
369,107
150,586
53,151
69,712
Total cash
408,250
194,422
64,383
94,022
Net receivables
172
1,802
1,015
3,162
Other current assets
2,589
3,421
2,315
5,057
Total current assets
410,839
197,843
66,698
99,079
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
27,647
28,501
35,907
32,295
Accumulated depreciation
-21,126
-21,237
-28,403
-26,184
Net property, plant and equipment
6,521
7,264
7,504
6,111
Goodwill
-
-
-
0
Intangible assets
27,190
30,690
48,690
48,690
Other long-term assets
104
41
41
1,929
Total non-current assets
33,815
37,995
56,235
56,730
Total assets
444,654
235,838
122,933
155,809
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
4,526
Accounts payable
1,228
1,048
1,174
1,069
Accrued liabilities
12,000
8,459
6,499
7,007
Other current liabilities
1,554
3,372
2,026
4,526
Total current liabilities
16,528
14,206
11,643
12,602
Non-current liabilities
Other long-term liabilities
7,354
10,121
15,551
19,147
Total non-current liabilities
8,650
12,275
17,264
19,147
Total liabilities
25,178
26,481
28,907
31,749
Stockholders' equity
Common stock
47
40
17
12
Retained earnings
-1,143,607
-1,073,096
-1,013,316
-962,438
Accumulated other comprehensive income
1,894
2,589
2,619
2,583
Total stockholders' equity
419,476
209,357
94,026
124,060
Total liabilities and stockholders' equity
444,654
235,838
122,933
155,809